Mike Spizzirri

• Oversaw strategic B2B software advertising campaigns for 20+ accounts with a $1.4M+ book of business
• Owned integrated scheduling, risk mitigation, and status reporting for high-priority projects, improving campaign performance by 30%
• Served as primary project liaison across internal stakeholders and client executives to define deliverables, ensure scope alignment, and manage project lifecycle
• Restructured internal Salesforce workflows, reducing delivery cycle time by 30% and accelerating revenue realization
• Created and presented strategic risk and opportunity reviews in quarterly business updates, contributing to $500K in client renewals

• Led global cross-functional teams (15+ staff) in delivering $25M+ in digital campaign initiatives for a Fortune 500 customer
• Spearheaded project scope, schedule, and cost tracking using Jira, Salesforce, and Workfront; completed key programs ahead of schedule and 10% under budget
• Managed project risk registers and performed ongoing schedule integration, ensuring continuous program delivery and stakeholder alignment
• Conducted weekly project milestone updates and financial reporting to senior leadership, driving informed business decisions and client trust
• Delivered results that boosted client satisfaction scores by 30% and retained $2.5M in contract value

• Managed Agile marketing technology projects from initiation through closure, overseeing SDLC coordination and Scrum ceremonies for a cross-functional team
• Achieved 50% increase in client online sales and $5M in new revenue through successful implementation of data-driven campaign strategies
• Initiated and tracked change requests, led stakeholder reporting cadence, and ensured adherence to compliance and delivery standards

• Managed regulatory mission planning for FDA device trials, creating detailed project roadmaps, clinical trial protocols, and milestone schedules
• Led daily planning scrums, sprint retrospectives, and long-range scheduling across engineering and clinical teams
• Reduced time-to-market by 20% and secured early FDA approvals through proactive issue mitigation and structured stakeholder collaboration
• Demonstrated consistent performance in meeting critical program milestones under tight time constraints and regulatory oversight